174 related articles for article (PubMed ID: 23494821)
1. Development and characterization of murine models of medulloblastoma extraneural growth in bone.
Grunda JM; Wang D; Clines GA
Clin Exp Metastasis; 2013 Aug; 30(6):769-79. PubMed ID: 23494821
[TBL] [Abstract][Full Text] [Related]
2. Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.
Cappellari AR; Rockenbach L; Dietrich F; Clarimundo V; Glaser T; Braganhol E; Abujamra AL; Roesler R; Ulrich H; Battastini AM
PLoS One; 2012; 7(10):e47468. PubMed ID: 23094051
[TBL] [Abstract][Full Text] [Related]
3. Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.
Zhao H; Cai W; Li S; Da Z; Sun H; Ma L; Lin Y; Zhi D
Childs Nerv Syst; 2013 Jul; 29(7):1097-105. PubMed ID: 23559392
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
[TBL] [Abstract][Full Text] [Related]
5. The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.
Thompson EM; Whitney NL; Wu YJ; Neuwelt EA
J Neurosurg Pediatr; 2013 Jan; 11(1):60-7. PubMed ID: 23082872
[TBL] [Abstract][Full Text] [Related]
6. Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles.
Peyrl A; Krapfenbauer K; Slavc I; Yang JW; Strobel T; Lubec G
Proteomics; 2003 Sep; 3(9):1781-800. PubMed ID: 12973738
[TBL] [Abstract][Full Text] [Related]
7. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
8. Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.
Li XN; Parikh S; Shu Q; Jung HL; Chow CW; Perlaky L; Leung HC; Su J; Blaney S; Lau CC
Clin Cancer Res; 2004 Feb; 10(3):1150-9. PubMed ID: 14871995
[TBL] [Abstract][Full Text] [Related]
9. Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.
Jaeger M; Nör C; de Farias CB; Abujamra AL; Schwartsmann G; Brunetto AL; Roesler R
Childs Nerv Syst; 2013 Dec; 29(12):2145-50. PubMed ID: 24092425
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract][Full Text] [Related]
11. Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
Chlapek P; Zitterbart K; Kren L; Filipova L; Sterba J; Veselska R
PLoS One; 2017; 12(2):e0172552. PubMed ID: 28231263
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma metastatic to the marrow. Report of four cases and review of the literature.
Spencer CD; Weiss RB; Van Eys J; Cohen P; Edwards B
J Neurooncol; 1984; 2(3):223-35. PubMed ID: 6502196
[TBL] [Abstract][Full Text] [Related]
13. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide resistance in medulloblastoma.
Friedman HS; Colvin OM; Kaufmann SH; Ludeman SM; Bullock N; Bigner DD; Griffith OW
Cancer Res; 1992 Oct; 52(19):5373-8. PubMed ID: 1356617
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
Wen DY; Hall WA; Conrad J; Godal A; Flørenes VA; Fodstad O
Neurosurgery; 1995 Jun; 36(6):1158-63; discussion 1163-4. PubMed ID: 7643997
[TBL] [Abstract][Full Text] [Related]
16. Differential role for protein kinase C-mediated signaling in the proliferation of medulloblastoma cell lines.
Adesina AM; Dooley N; Yong VW; Nalbantoglu J
Int J Oncol; 1998 Apr; 12(4):759-68. PubMed ID: 9499434
[TBL] [Abstract][Full Text] [Related]
17. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
[TBL] [Abstract][Full Text] [Related]
18. Distinct patterns of human medulloblastoma dissemination in the developing chick embryo nervous system.
Cage TA; Louie JD; Liu SR; Alvarez-Buylla A; Gupta N; Hyer J
Clin Exp Metastasis; 2012 Apr; 29(4):371-80. PubMed ID: 22322278
[TBL] [Abstract][Full Text] [Related]
19. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.
Blazek ER; Foutch JL; Maki G
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):1-5. PubMed ID: 17084552
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell stemness, responses to experimental genotoxic treatments, cytomegalovirus protein expression and DNA replication stress in pediatric medulloblastomas.
Bartek J; Merchut-Maya JM; Maya-Mendoza A; Fornara O; Rahbar A; Bröchner CB; Sehested A; Söderberg-Nauclér C; Bartek J; Bartkova J
Cell Cycle; 2020 Apr; 19(7):727-741. PubMed ID: 32054408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
